Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Report

Global and Region Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：199
  • REPORT CODE：GMM895204
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Granulocyte-Colony Stimulating Factor (G-CSF) Drugsmarket, defines the market attractiveness level of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs industry, describes the types of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market and the development prospects and opportunities of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market in Chapter 13.

    By Player:

    • Intas

    • North China Pharmaceutical

    • SL Pharm

    • Amoytop

    • Merck

    • Kyowa Kirin

    • Dr Reddy

    • GenSci

    • Pfizer

    • Chugai Pharmaceutical

    • Novartis

    • Amgen

    • Dong-A Socio

    • Hayao Group

    • Teva

    By Type:

    • Filgrastim

    • Pefigrastim

    • Lipefigrastim

    By End-User:

    • Oncology

    • Blood Disease

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption (2017-2022)

    • 7.2 United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption (2017-2022)

    • 7.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption (2017-2022)

    • 7.4 China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption (2017-2022)

    • 7.5 Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption (2017-2022)

    • 7.6 India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption (2017-2022)

    • 7.7 South Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption (2017-2022)

    8 Region and Country-wise Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast (2022-2028)

    • 8.4 China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast (2022-2028)

    • 8.6 India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast (2022-2028)

    9 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Filgrastim Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pefigrastim Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Lipefigrastim Consumption and Growth Rate (2017-2022)

    • 9.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Blood Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Filgrastim Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Pefigrastim Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Lipefigrastim Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Blood Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Competitive Analysis

    • 14.1 Intas

      • 14.1.1 Intas Company Details

      • 14.1.2 Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.2 North China Pharmaceutical

      • 14.2.1 North China Pharmaceutical Company Details

      • 14.2.2 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.3 SL Pharm

      • 14.3.1 SL Pharm Company Details

      • 14.3.2 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.4 Amoytop

      • 14.4.1 Amoytop Company Details

      • 14.4.2 Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.5 Merck

      • 14.5.1 Merck Company Details

      • 14.5.2 Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.6 Kyowa Kirin

      • 14.6.1 Kyowa Kirin Company Details

      • 14.6.2 Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.7 Dr Reddy

      • 14.7.1 Dr Reddy Company Details

      • 14.7.2 Dr Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Dr Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.8 GenSci

      • 14.8.1 GenSci Company Details

      • 14.8.2 GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.10 Chugai Pharmaceutical

      • 14.10.1 Chugai Pharmaceutical Company Details

      • 14.10.2 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.11 Novartis

      • 14.11.1 Novartis Company Details

      • 14.11.2 Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.12 Amgen

      • 14.12.1 Amgen Company Details

      • 14.12.2 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.13 Dong-A Socio

      • 14.13.1 Dong-A Socio Company Details

      • 14.13.2 Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.14 Hayao Group

      • 14.14.1 Hayao Group Company Details

      • 14.14.2 Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • 14.15 Teva

      • 14.15.1 Teva Company Details

      • 14.15.2 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs

    • Figure Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Picture

    • Table Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption by Country (2017-2022)

    • Figure United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Filgrastim Consumption and Growth Rate (2017-2022)

    • Figure Global Pefigrastim Consumption and Growth Rate (2017-2022)

    • Figure Global Lipefigrastim Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Filgrastim Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pefigrastim Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lipefigrastim Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Intas (Foundation Year, Company Profile and etc.)

    • Table Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table North China Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table SL Pharm (Foundation Year, Company Profile and etc.)

    • Table SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Amoytop (Foundation Year, Company Profile and etc.)

    • Table Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Kyowa Kirin (Foundation Year, Company Profile and etc.)

    • Table Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Dr Reddy (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table GenSci (Foundation Year, Company Profile and etc.)

    • Table GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Chugai Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Dong-A Socio (Foundation Year, Company Profile and etc.)

    • Table Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Hayao Group (Foundation Year, Company Profile and etc.)

    • Table Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US